Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $18,693.29 in Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the business’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total value of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]

Related Keywords

United States ,America ,Chrisa Rallis , ,Jpmorgan Chase Co ,News Ratings For Fennec Pharmaceuticals Daily ,Securities Exchange Commission ,Quarter For Fennec Pharmaceuticals ,Institutional Trading Of Fennec Pharmaceuticals ,Fennec Pharmaceuticals ,Barclays Plc ,Fennec Pharmaceuticals Inc ,Fennec Pharmaceuticals Stock ,Cantor Fitzgerald ,America Corp ,Boothbay Fund Management ,Free Report ,Director Chris ,Exchange Commission ,Pharmaceuticals Inc ,Fund Management ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,Nasdaq Fenc ,Pufenc ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,